Navigation Links
Brazil Will Purchase Merck’s Antiretroviral If Price Not Lowere

Brazilian Health Minister Jose Gomes Temporao on Wednesday signed a decree declaring that the country would purchase from an India-based drug maker a generic version of Merck's// antiretroviral Efavirenz if the company does not offer the drug at a lower price.

According to the decree, Efavirenz is a "public interest" medicine. Temporao at a news conference said the country did not issue the decree "as a threat, nor to lower the price of other medicines, but to guarantee its program of attending (AIDS) patients." Brazil has given Merck seven days to negotiate a lower price for the drug.

According to the AP/Forbes, if the two sides do not agree on a lower price, Brazil could break Merck's patent of the drug by issuing a compulsory license to produce or purchase a lower-cost version of the drug.

World Trade Organization regulations allow governments to declare a "national emergency" and issue compulsory licenses on any grounds without consulting the foreign patent owner.

Merck spokesperson Amy Rose said the company "does not believe compulsory licensing is in the best interest of patients," adding that Merck is committed to reaching an agreement with Brazil. Brazil and Merck in November 2006 began negotiations over Efavirenz.

According to the AP/Forbes, Brazil called on Merck to provide the drug at 65 cents per 600 mg dose -- the same price the company charges the Thai government. At the time, Brazil was paying $1.59 per dose, according to the decree.

Merck offered to reduce the price of Efavirenz in Brazil by 2%, but the country rejected the offer. About 75,000 of the 180,000 HIV-positive Brazilians who receive access to no-cost antiretrovirals from the government use Efavirenz, according to the AP/Forbes.

Brazil in 2005 reached an agreement with Abbott Laboratories over the price of its antiretroviral Kaletra after the country said it would break the drug's patent if its price
'"/>




Page: 1 2

Related medicine news :

1. Brazil & Kenya Seek Support For A New Resolution At WHO’s Annual Mee
2. Brazilian Women to Be Vaccinated To Prevent Uterine Cancer
3. Malaria and TB Kills Indian Kids in Brazil
4. 13,000 Cases of Dengue Found in Brazil in January
5. Down Syndrome Dolls in Brazil After Child Actors Success
6. Brazil’s Claim to Fame - Fat Women and Drunk Men, Survey Find
7. Brazilian Boost for Bird Flu Vaccines
8. Brazil Spider Offers Hope for Those Suffering from Erectile Dysfunction
9. Brazil Government In Contention With Merck Over Anti-AIDS Drug
10. The Risks Involved In Purchase Of Over The Counter Medications
11. Online Auction Results In Purchase of Chemicals

Post Your Comments:
(Date:11/8/2009)...network of Hispanic health advocates committed to ..., WASHINGTON, Nov. 7 ... they have heard the voice of America,s families b...ct. Now the Senate must deliver, without delay, on...id Dr. Jane L. Delgado, President and CEO of the N...
(Date:11/8/2009)...assage of H.R. 3961 to Secure the Stability of Med...e/ -- Statement Attributable to: J. James Rohack, ..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...e of the House health reform bill, which will help...ians and calls for swift passage of H.R. 3961 to s...
(Date:11/8/2009)...Shows Who Sides With Working Families vs. Insuranc...wire-USNewswire/ -- On the heels of an historic la...a good, balanced health care reform bill, the Penn...tate,s U.S. representatives voted on HR 3962, the ... legislation, which passed Saturday evening by a v...
(Date:11/7/2009)... Karen Ignagni, Preside...IP), released the following statement today on Hou...gly support comprehensive health care reform, and ...g a complete overhaul of how health insurance is p... coverage, elimination of pre-existing condition e...
(Date:11/7/2009)...RNewswire-USNewswire/ -- The American Medical Asso...or of Health at the Family Violence Prevention Fun...ay at its semi-annual policy-making meeting. The ...honor the AMA House of Delegates bestows on a non-...m/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ms. Jam...
Breaking Medicine News(10 mins):Health News:National Alliance for Hispanic Health President and CEO Applauds House Action, Calls on Senate to Pass Health Reform in 2009 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA Honors Family Violence Prevention Expert 2
... on animal health has declared India as free from ...disease affecting the intestinal tract of cattle /...inderpest infection is a great achievement. It is ...ministry said in a statement Friday. 'This f...
...ader Sri Sri Ravishankar has said practising yoga,...away from drug and alcohol abuse. // 'Youths...to introduce yoga, pranayam and dhyan (meditation)...vi Shankar appealed to the youths to take up yoga ...
...rotests witnessed last month against the governmen...tions of higher education were a creation //of the...id here Friday 'The resistance (to the propo...ntral educational institutions, he said all politi...
... the research conducted by the U.S. Department of ...gues at Stony Brook University // , the IRCCS Neur...rsity it was found that improvements in the existi...ially tested on rats and the results of the study ...
...he Pentagon placed new restrictions on a doctors’...ere against any policy //that gives medical profe...ogaters’ to use harsher tactics than they would i... rights groups and medical ethicists. They charge ...
...government has cancelled examinations for recruitm... thereby providing more opportunities // to over 1...o low demand, we have cancelled all PLAB (Professi...t announced. Shiv Pande, Chairman of Indo-Bri...
Other Medicine News:Health News:India Declared Free of Rinderpest Cattle Infection 2Health News:Radiation Therapy Made More Compatible 2Health News:Radiation Therapy Made More Compatible 3Health News:Medical Role In Interrogations Curtailed By Pentagon 2
(Date:11/6/2009)...re-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA ), ...ducts for minimally disruptive surgical treatments... Michael J. Lambert as Executive Vice President an...009. The Company also announced several other Exe...l be an excellent complement to the NuVasive famil...
(Date:11/6/2009)...re-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: ...velopment of small-molecule therapeutics for the t...y virus (HIV), today reported recent accomplishmen... nine months ended September 30, 2009. ,, (Log...ARDEALOGO ) ,, "Since our last quarterly update...
(Date:11/6/2009)...re/ -- NexBio Inc., in collaboration with scientis...on (CDC), St. Louis University, and the University...two articles in the peer-reviewed journal PLoS ONE... (Fludase ® ) may play a potentially importan...demic Influenza A(H1N1) and drug-resistant influen...
Breaking Medicine Technology:NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 2Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 3Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 4Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 5Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 6Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 7Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results 8NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 1LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense 53923 2National Alliance for Hispanic Health Applauds Confirmation of Sonia Sotomayor as the Nations 111th Supreme Court Justice 53920 1The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 1The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 2The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 3The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 4The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 5The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 6The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 7The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 8The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 9The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 10The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 11The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 12The Ensign Group Reports Second Quarter 2009 Earnings of 240 39 per Share 3B Reaffirms 2009 EPS Guidance 53917 13
...-(BUSINESS WIRE)--Mar 26, 2007 - A study comparing...nd hydralazine,(HYD) used in V-HeFT I and V-HeFT I...on, used in the African American Heart Failure,Tri...oequivalence,in the formulations used may explain ...esults in decreasing mortality. Using,identical am...
...atients already being treated with maximally,toler...her,reductions in LDL-C with similar reductions in...SIS 301012, NEW ORLEANS, and CARLSBAD, Calif., Mar...euticals, Inc. announced,results from its ongoing ...with homozygous familial hypercholesterolemia (HoF...
Other Medicine Technology:Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 2Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 3Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 4Study: Identical Doses of BiDil Components Are Not Bioequivalent to,the Fixed Dose Combination-BiDil-Used in A-HeFT 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 2Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 3Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 4Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 5Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 301012,in Familial Hypercholesterolemia Patients Presented at ACC 6
E300 Corneal Topographer
...NPstream Genotyping System provides an automated s... over 800,000 SNP genotypes per day. Combined with...nd operational flexibility, this enables you to pr...st solution designed to deliver your intended resu...
...e upgrade including fourSight 4D ultrasound imagin...ystem offers a wide variety of imaging and workflo...atures that combine to expand the clinical capabil...ares system was built on four foundations that mar...
... laser-cut stent, is the latest in a succession of...y arteries have been opened with balloon catheters...oronary angioplasty (PTCA). The BeStent2 stent sys...optimize scaffolding, radiopacity and deliverabili...
Medicine Products: